The Rationale of Inositol Therapy in Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS)'s rate is about 6% to10% among the reproductive aged women; it is characterized by menstrual cycle irregularity with oligoanovulation, hyperandrogenism, insulin resistance, and compensatory hyperinsulinemia

Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease

Laganà, As
Primo
;
Chiofalo, B;Vitale, Sg.
Ultimo
2017

Abstract

The Rationale of Inositol Therapy in Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS)'s rate is about 6% to10% among the reproductive aged women; it is characterized by menstrual cycle irregularity with oligoanovulation, hyperandrogenism, insulin resistance, and compensatory hyperinsulinemia
File in questo prodotto:
File Dimensione Formato  
Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome.pdf

accesso aperto

Descrizione: Full text articolo pubblicato su rivista
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 82.01 kB
Formato Adobe PDF
82.01 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3111776
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 65
  • ???jsp.display-item.citation.isi??? 55
social impact